CPJE: Controlled Substances part 1
UPDATED Exam Questions and
CORRECT Answers
Schedule I - CORRECT ANSWER - No currently accepted medical use; high potential for
abuse and lack of accepted safety under medical supervision
Schedule II - CORRECT ANSWER - High potential for abuse; abuse may cause severe
psychological or physical dependence
Schedule III - CORRECT ANSWER - Lower abuse potential than schedules I and II;
abuse may cause moderate or low potential for physical dependence or high psychological
dependence
Schedule IV - CORRECT ANSWER - Low potential for abuse relative to schedule III;
abuse may cause limited physical or psychological dependence relative to schedule III
Schedule V - CORRECT ANSWER - Low potential for abuse relative to schedule IV;
abuse may cause limited physical or psychological dependence relative to schedule IV
Schedule I Drugs - CORRECT ANSWER - - 3,4 methylenedioxymethamphetamine or
MDMA
- Gamma-hydroxybuyric acid (GHB) (sodium salt forma, sodium oxybate is schedule III)
- Heroin
- Lysergic acid diethylamide (LSD)
- Marijuana (Cannabis sativa), per DEA
- Mescaline
- Peyote
Alfenatil - CORRECT ANSWER - Schedule II opioid
, Codeine - CORRECT ANSWER - Schedule II opioid
Actiq (lozenge), Duragesic, Fentora, Lazanda (nasal spray), Sublimaze (injection), Subsys (SL
spray) - CORRECT ANSWER - Fentanyl
- Schedule II
Hysingla ER, Zohydro ER - CORRECT ANSWER - Hydrocodne ER
Schedule II
Lortab, Norco, TussiCaps, Tussionex (solution), Vicodin, Vicoprofen (w/ ibuprofen) -
CORRECT ANSWER - Hydrocone combo products
Schedule II
Dilaudid - CORRECT ANSWER - Hydromorphone
Schedule II
Levorphanol - CORRECT ANSWER - Schedule II opioid
Demerol - CORRECT ANSWER - Meperidine
schedule II
Methadone HCl Intensol, Methadose - CORRECT ANSWER - Methadone
Schedule II
Kadian (ER), MS Contin (CR), Mitigo (injectable), Duramorph (IR), Infumorph (IR) -
CORRECT ANSWER - Morphine
Schedule II
UPDATED Exam Questions and
CORRECT Answers
Schedule I - CORRECT ANSWER - No currently accepted medical use; high potential for
abuse and lack of accepted safety under medical supervision
Schedule II - CORRECT ANSWER - High potential for abuse; abuse may cause severe
psychological or physical dependence
Schedule III - CORRECT ANSWER - Lower abuse potential than schedules I and II;
abuse may cause moderate or low potential for physical dependence or high psychological
dependence
Schedule IV - CORRECT ANSWER - Low potential for abuse relative to schedule III;
abuse may cause limited physical or psychological dependence relative to schedule III
Schedule V - CORRECT ANSWER - Low potential for abuse relative to schedule IV;
abuse may cause limited physical or psychological dependence relative to schedule IV
Schedule I Drugs - CORRECT ANSWER - - 3,4 methylenedioxymethamphetamine or
MDMA
- Gamma-hydroxybuyric acid (GHB) (sodium salt forma, sodium oxybate is schedule III)
- Heroin
- Lysergic acid diethylamide (LSD)
- Marijuana (Cannabis sativa), per DEA
- Mescaline
- Peyote
Alfenatil - CORRECT ANSWER - Schedule II opioid
, Codeine - CORRECT ANSWER - Schedule II opioid
Actiq (lozenge), Duragesic, Fentora, Lazanda (nasal spray), Sublimaze (injection), Subsys (SL
spray) - CORRECT ANSWER - Fentanyl
- Schedule II
Hysingla ER, Zohydro ER - CORRECT ANSWER - Hydrocodne ER
Schedule II
Lortab, Norco, TussiCaps, Tussionex (solution), Vicodin, Vicoprofen (w/ ibuprofen) -
CORRECT ANSWER - Hydrocone combo products
Schedule II
Dilaudid - CORRECT ANSWER - Hydromorphone
Schedule II
Levorphanol - CORRECT ANSWER - Schedule II opioid
Demerol - CORRECT ANSWER - Meperidine
schedule II
Methadone HCl Intensol, Methadose - CORRECT ANSWER - Methadone
Schedule II
Kadian (ER), MS Contin (CR), Mitigo (injectable), Duramorph (IR), Infumorph (IR) -
CORRECT ANSWER - Morphine
Schedule II
